Acetic Acid

Acetic Acid

SCHEMBL5986264

CC(=O)O.NC(O)C(O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.50
LCK P06239 1/20 0.50
FYN P06241 1/20 0.50
TP53 P04637 1/20 0.39
SLC7A5 Q01650 2/20 0.38
LMNA P02545 2/20 0.38
ALOX15 P16050 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
GABRP O00591 4/20 0.33
GABRD O14764 4/20 0.33
GABRA1 P14867 4/20 0.33
GABRB1 P18505 4/20 0.33
GABRG2 P18507 4/20 0.33
GABRB3 P28472 4/20 0.33
GABRA5 P31644 4/20 0.33
GABRA3 P34903 4/20 0.33
GABRA2 P47869 4/20 0.33
GABRB2 P47870 4/20 0.33
GABRA4 P48169 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL9151775 0.85 FFAR3 (0.58) FFAR3LCKFYNTP53SLC7A5
Acetic Acid SCHEMBL1565106 0.81
Acetic Acid SCHEMBL4292108 0.81 FFAR3 (0.54) FFAR3LCKFYNTP53SLC7A5
Acetic Acid SCHEMBL10589745 0.81
Acetic Acid SCHEMBL6425236 0.79 FFAR3 (0.50) FFAR3LCKFYNTP53SLC7A5
Propionic Acid SCHEMBL23466906 0.78 FFAR3 (0.59) FFAR3TP53SLC7A5LMNAGABRP
Acetic Acid SCHEMBL44094 0.77
Acetic Acid SCHEMBL28157960 0.77
Acetic Acid SCHEMBL670655 0.77 FFAR3 (0.58) FFAR3LCKFYNTP53SLC7A5
Acetic Acid SCHEMBL27717337 0.77 FFAR3 (0.58) FFAR3LCKFYNTP53SLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060110379-A1 Linkage of agents using microparticles PERICOR SCIENCE, INC. (US) 2006-05-25 US disclosed
US-20060104966-A1 Transglutaminase linkage of agents to tissue PERICOR SCIENCE, INC. (US) 2006-05-18 US disclosed
US-6958148-B1 Linkage of agents to body tissue using microparticles and transglutaminase PERICOR SCIENCE, INC. (US) 2005-10-25 US disclosed
WO-2005092273-A2 METHOD OF COMPATIBILIZING CATIONIC MATERIALS WITH ANIONIC POLYMERS NOVEON IP HOLDINGS CORP. (US) 2005-10-06 WO disclosed
CN-1678282-A Compositions of anionic polymeric rheology modifiers and cationic materials NOVEON IP HOLDINGS CORP (US) 2005-10-05 CN disclosed
US-6919076-B1 Conjugates of agents and transglutaminase substrate linking molecules PERICOR SCIENCE, INC. (US) 2005-07-19 US disclosed
EP-1534221-A1 COMPOSITIONS OF ANIONIC POLYMERIC RHEOLOGY MODIFIERS AND CATIONIC MATERIALS Noveon IP Holdings Corp. (US) 2005-06-01 EP disclosed
US-20040170587-A1 Method of compatibilizing cationic materials with anionic polymers LUBRIZOL ADVANCED MATERIALS, INC. 2004-09-02 US disclosed
WO-2004026271-A1 COMPOSITIONS OF ANIONIC POLYMERIC RHEOLOGY MODIFIERS AND CATIONIC MATERIALS NOVEON IP HOLDINGS CORP. (US) 2004-04-01 WO disclosed
US-20040052748-A1 Compositions of anionic polymeric rheology modifiers and cationic materials LUBRIZOL ADVANCED MATERIALS, INC. 2004-03-18 US disclosed
EP-1303260-A2 LINKAGE OF AGENTS USING MICROPARTICLES Pericor Science, Inc. (US) 2003-04-23 EP disclosed
EP-1203141-A1 LINKAGE OF AGENTS TO TISSUE Pericor Science, Inc. (US) 2002-05-08 EP disclosed
EP-1202706-A1 LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE Pericor Science, Inc. (US) 2002-05-08 EP disclosed
WO-2002007707-A2 LINKAGE OF AGENTS USING MICROPARTICLES PERICOR SCIENCE, INC. (US) 2002-01-31 WO disclosed
WO-2001007009-A1 LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE PERICOR SCIENCE, INC. (US) 2001-02-01 WO disclosed
WO-2001006829-A2 LINKAGE OF AGENTS TO TISSUE PERICOR SCIENCE, INC. (US) 2001-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040170587-A1 Method of compatibilizing cationic materials with anionic polymers PARN, PARG, PICALM FFAR3 4365/4885LCK 4266/4885FYN 3497/4885
US-20040052748-A1 Compositions of anionic polymeric rheology modifiers and cationic materials PBRM1, PARG, PARN FFAR3 3015/4885LCK 2412/4885FYN 1440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.